Nikko Asset Management Americas, Inc. Beam Therapeutics Inc. Transaction History

Nikko Asset Management Americas, Inc.

$8.64 Billion
Q3 2024

A detailed history of Nikko Asset Management Americas, Inc. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 3,552,829 shares of BEAM stock, worth $95.4 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares

3,552,829

Previous 2,224,415 59.72%

Holding current value

$95.4 Million

Previous $52.1 Million 67.01%

% of portfolio

1.01%

Previous 0.61%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$22.57 - $33.14 $30 Million - $44 Million	1,328,414 Added 59.72%	3,552,829 $87 Million
Q2 2024 Aug 09, 2024	SELL	$21.22 - $32.66 $2.92 Million - $4.49 Million	-137,402 Reduced 5.82%	2,224,415 $52.1 Million
Q1 2024 May 02, 2024	BUY	$23.46 - $45.07 $87,411 - $167,930	3,726 Added 0.16%	2,361,817 $78 Million
Q4 2023 Feb 08, 2024	BUY	$17.69 - $30.76 $12.7 Million - $22 Million	715,911 Added 43.6%	2,358,091 $64.2 Million
Q3 2023 Nov 09, 2023	BUY	$23.01 - $32.46 $9.83 Million - $13.9 Million	427,100 Added 35.15%	1,642,180 $39.5 Million
Q2 2023 Aug 14, 2023	BUY	$29.32 - $35.99 $16.3 Million - $20 Million	556,514 Added 84.5%	1,215,080 $38.8 Million
Q1 2023 May 03, 2023	SELL	$30.15 - $48.79 $455,988 - $737,899	-15,124 Reduced 2.24%	658,566 $20.2 Million
Q4 2022 Feb 13, 2023	BUY	$36.73 - $51.6 $5.98 Million - $8.4 Million	162,759 Added 31.86%	673,690 $26.3 Million
Q3 2022 Nov 14, 2022	BUY	$39.79 - $70.31 $8.71 Million - $15.4 Million	218,969 Added 75.0%	510,931 $23.8 Million
Q2 2022 Aug 04, 2022	BUY	$29.86 - $62.36 $252,406 - $527,129	8,453 Added 2.98%	291,962 $10.8 Million
Q1 2022 May 06, 2022	BUY	$53.73 - $82.16 $3.13 Million - $4.79 Million	58,286 Added 25.88%	283,509 $16.3 Million
Q4 2021 Feb 08, 2022	SELL	$68.02 - $99.06 $1.98 Million - $2.89 Million	-29,132 Reduced 11.45%	225,223 $18 Million
Q3 2021 Nov 09, 2021	BUY	$84.37 - $133.6 $61,083 - $96,726	724 Added 0.29%	254,355 $22.1 Million
Q2 2021 Aug 09, 2021	BUY	$64.12 - $128.71 $1.55 Million - $3.12 Million	24,230 Added 10.56%	253,631 $33 Million
Q1 2021 May 03, 2021	BUY	$71.28 - $120.75 $1.79 Million - $3.04 Million	25,159 Added 12.32%	229,401 $18.4 Million
Q4 2020 Feb 11, 2021	BUY	$22.24 - $95.63 $4.54 Million - $19.5 Million	204,242 New	204,242 $16.7 Million

Others Institutions Holding BEAM

# of Institutions

236

Shares Held

75.2M

Call Options Held

438K

Put Options Held

232K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.89B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.

Account

Nikko Asset Management Americas, Inc. Beam Therapeutics Inc. Transaction History